India to issue second cancer drug compulsory licence #pharma #compulsorylicense

Mint is reporting today that India will soon issue its compulsory licence for a cancer drug. A CL allows generic manufacturers to produce a medicine even if the discoverer of the product still has a valid patent. India issued its first patent (for Bayer’s Nexavar) last year. The Indian generic version of that drug is …

India to issue second cancer drug compulsory licence #pharma #compulsorylicense Read More »